Christopher Causey - Net Worth and Insider Trading
Christopher Causey Net Worth
The estimated net worth of Christopher Causey is at least $1 Million dollars as of 2024-11-29. Christopher Causey is the Director of United Therapeutics Corp and owns about 3,675 shares of United Therapeutics Corp (UTHR) stock worth over $1 Million. Details can be seen in Christopher Causey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Causey has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Causey
Christopher Causey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Causey owns 1 companies in total, including United Therapeutics Corp (UTHR) .
Click here to see the complete history of Christopher Causey’s form 4 insider trades.
Insider Ownership Summary of Christopher Causey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-11-01 | director |
Christopher Causey Latest Holdings Summary
Christopher Causey currently owns a total of 1 stock. Christopher Causey owns 3,675 shares of United Therapeutics Corp (UTHR) as of November 1, 2024, with a value of $1 Million.
Latest Holdings of Christopher Causey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-11-01 | 3,675 | 378.13 | 1,389,628 |
Holding Weightings of Christopher Causey
Christopher Causey Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Causey has made a total of 13 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in United Therapeutics Corp is the sale of 510 shares on November 1, 2024, which brought Christopher Causey around $192,081.
Insider Trading History of Christopher Causey
- 1
Christopher Causey Trading Performance
Christopher Causey Ownership Network
Christopher Causey Owned Company Details
What does United Therapeutics Corp do?
Who are the key executives at United Therapeutics Corp?
Christopher Causey is the director of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , EVP & General Counsel Paul A Mahon , and CFO and Treasurer James Edgemond .
United Therapeutics Corp (UTHR) Insider Trades Summary
Over the past 18 months, Christopher Causey made 8 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 14,360. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 130,200 shares made by Paul A Mahon , and a net sale of 133,718 shares made by James Edgemond .
In summary, during the past 3 months, insiders sold 177,815 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 177,815 shares. During the past 18 months, 1,143,835 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,143,835 shares.
United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.
United Therapeutics Corp Insider Transactions
Christopher Causey Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Causey. Currently GuruFocus does not have mailing address information for Christopher Causey.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
